Search research articles
Contact Us
Filters
Showing results (481-490 of 534) with videos related to
Page
of 54
Sort By:
The British Journal of Dermatology
|
October 12, 2018
Sunscreen applied at ≥ 2 mg cm<sup>-2</sup> during a sunny holiday prevents erythema, a biomarker of ultraviolet radiation-induced DNA damage and suppression of acquired immunity
J Narbutt, P A Philipsen, G I Harrison, et al.
Journal for Immunotherapy of Cancer
|
November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
The Review of Scientific Instruments
|
October 2, 2007
Controller-area-network bus control and monitor system for a radio astronomy interferometer
David P Woody, Bradley Wiitala, Stephen L Scott, et al.
Oncoimmunology
|
May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma
Meghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 28, 2023
Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation
Liam S P Lawrence, Rachel W Chan, Hanbo Chen, et al.
Journal of AOAC International
|
March 12, 2005
Microbiological assay-trienzyme procedure for total folates in cereals and cereal foods: collaborative study
Jonathan W DeVries, Jeanne I Rader, Pamela M Keagy, et al.
The Lancet. Oncology
|
June 9, 2016
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, et al.
Plos One
|
July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
Page
of 54
Search research articles
Search
Showing results (481-490 of 534) with videos related to
Sort By:
Page
of 54
The British Journal of Dermatology
|
October 12, 2018
Sunscreen applied at ≥ 2 mg cm<sup>-2</sup> during a sunny holiday prevents erythema, a biomarker of ultraviolet radiation-induced DNA damage and suppression of acquired immunity
J Narbutt, P A Philipsen, G I Harrison, et al.
Journal for Immunotherapy of Cancer
|
November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2016
An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Danny N Khalil, Michael A Postow, Nageatte Ibrahim, et al.
The Review of Scientific Instruments
|
October 2, 2007
Controller-area-network bus control and monitor system for a radio astronomy interferometer
David P Woody, Bradley Wiitala, Stephen L Scott, et al.
Oncoimmunology
|
May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma
Meghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events
Steven M Blum, Ben Ouyang, Leyre Zubiri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 28, 2023
Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation
Liam S P Lawrence, Rachel W Chan, Hanbo Chen, et al.
Journal of AOAC International
|
March 12, 2005
Microbiological assay-trienzyme procedure for total folates in cereals and cereal foods: collaborative study
Jonathan W DeVries, Jeanne I Rader, Pamela M Keagy, et al.
The Lancet. Oncology
|
June 9, 2016
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Jeffrey S Weber, Geoff Gibney, Ryan J Sullivan, et al.
Plos One
|
July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
Page
of 54